dr now glp-1 FDA Approves First Pill blackdoctorsspeak #glp1 #weightlossrevolution #healthequity |

Other causes, such as irritable bowel syndrome (IBS),14 inflammatory bowel disease (IBD), colonic neoplasms, and hyperplastic polyps, could also contribute to the onset of MC.13,15 Some studies show that MC may be connected to the use of non-steroidal anti-inflammatory drugs (NSAIDs),16 vitamin E (VE) deficiency, the intake of unsaturated fatty acids,17 environmental factors,18 family history,3 psoriasis19 and Rett syndrome.20 Feces stasis also plays an important role in the pathogenesis of MC

Over-loss and muscle pooled SURMOUNT, BMI below 22 reached by about 7% (as early as week 12), toward about 15% by week 88 in the longest trial, clinical underweight under 0.4% (Almandoz 2026)

Sold as Mounjaro (for diabetes) and Zepbound (for weight management), tirzepatide has quickly become the most prescribed alternative for people who want more weight loss than semaglutide delivers

Oral GLP-1s cause weight loss, and for Alzheimer's patients who are already at increased risk of frailty that weight loss includes dangerous muscle mass loss